Carnitine effects on coenzyme A profiles in rat liver with hypoglycin inhibition of multiple dehydrogenases

American Journal of Physiology - Endocrinology and Metabolism

Volumn 272, Issue 3 35-3, 1997, Pages

  Lieu, Yen K ^a   Hsu, Betty Y L ^a   Price, William A ^b   Corkey, Barbara E ^c   Stanley, Charles A ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b LA SALLE UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

acyl CoA dehydrogenase; fatty acid oxidation; ketogenesis; methylenecyclopropaneacetic acid; multiple acyl CoA dehydrogenation deficiencies; spiropentaneacetic acid

Indexed keywords

ACYL COENZYME A; ACYL COENZYME A DEHYDROGENASE; CARNITINE; HYPOGLYCINE A; OXIDOREDUCTASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FATTY ACID OXIDATION; INBORN ERROR OF METABOLISM; KETOGENESIS; LIVER CELL CULTURE; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030995186     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1997.272.3.e359     Document Type: Article

References (27)

1. Becker, C. M., and R. A. Harris. Influence of valproic acid on hepatic carbohydrate and lipid metabolism. Arch. Biochem. Biophys. 223: 381-392, 1983.
2. Brass, E. P. Overview of coenzyme A metabolism and its role in cellular toxicity. Chem. Biol. Interact. 90: 203-214, 1994.
3. Brass, E. P. Interaction of carnitine and propionate with pyruvate oxidation by hepatocytes from clofibrate-treated rats: importance of coenzyme A availability. J. Nutr. 122: 234-240, 1992.
4. Bressler, R., C. Corredor, and K. Brendel. Hypoglycin and hypoglycin-like compounds. Pharmacol. Rev. 21: 105-130, 1969.
5. Corkey, B. E. Analysis of acyl-coenzyme A esters in biological samples. Methods Enzymol. 166: 55-70, 1988.
6. Corkey, B. E., A. Martin-Requero, E. Wlaijtys-Rode, R. J. Williams, and J. R. Williamson. Regulation of the branched chain alpha-ketoacid pathway in liver. J. Biol. Chem. 257: 9668-9676, 1982.
7. Entman, M., and R. Bressler. The mechanism of action of hypoglycin on long-chain fatty acid oxidation. Mol. Pharmacol. 3: 333-340, 1967.
8. Frerman, F. E., and S. I. Goodman. Nuclear-encoded defects of the mitochondrial respiratory chain, including glutaric acidemia type II. In: The Metabolic and Molecular Basis of Inherited Disease, edited by C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle. New York: McGraw-Hill, 1995, p. 1611-1630.
9. Fukami, M. H., and J. R. Williamson. On the mechanism of inhibition of fatty acid oxidation by 4-pentenoic acid in rat liver mitochondria. J. Biol. Chem. 246: 1206-1212, 1971.
10. Hale, D. E., M. L. Batshaw, P. M. Coates, F. E. Frerman, S. I. Goodman, I. Singh, and C. A. Stanley. Long-chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia. Pediatr. Res. 19: 666-671, 1985.
11. Husain, M., and S. J. Steenkamp. Electron transfer flavoprotein from pig liver mitochondria. Biochem. J. 209: 541-545, 1983.
12. Kobayashi, A., and S. Fujisawa. Effect of L-carnitine on mitochondrial acyl CoA esters in the ischemic dog heart. J. Mol. Cell. Cardiol. 26: 499-508, 1994.
13. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
14. Roe, C. R., and P. M. Coates. Mitochondrial fatty acid oxidation disorders. In: The Metabolic and Molecular Basis of Inherited Disease, edited by C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle. New York: McGraw Hill, 1995, p. 1501-1534.
15. Ruff, L. J., and E. P. Brass. Metabolic effects of pivalate in isolated rat hepatocytes. Toxicol. Appl. Pharmacol. 110: 295-302, 1991.
16. Russo, J. M., and W. A. Price. Mild, efficient trimethylaluminum-mediated cyclopropanations. An innovative synthesis of the new dehydrogenase inhibitor spiropentaneacetic acid. J. Org. Chem. 58: 3589-3590, 1993.
17. Sewell, A. C., S. W. Bender, S. Wirth, H. Munterfering, L. Ijlist, and R. J. Wanders. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a severe fatty acid oxidation disorder. Eur. J. Pediatr. 153: 745-750, 1994.
18. Sherratt, H. S. A., and H. Osmundsen. Commentary: on the mechanisms of some pharmacological actions of the hypoglycaemic toxins hypoglycin and pent-4-enoic acid. A way out of the present confusion. Biochem. Pharmacol. 25: 743-750, 1976.
19. Stanley, C. A. Carnitine disorders. Adv. Pediatr. 42: 209-242, 1995.
20. Stanley, C. A. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency. Adv. Pediatr. 34: 59-88, 1987.
21. Tanaka, K., and Y. Ikeda. Hypoglycin and Jamaican vomiting sickness. Prog. Clin. Biol. Res. 321: 167-184, 1990.
22. Tserng, K. Y., S. J. Jin, and C. L. Hoppel. Spiropentaneacetic acid as a specific inhibitor of medium-chain acyl-CoA dehydrogenase. Biochemistry 30: 10755-10760, 1991.
23. Wenz, A., S. Ghisla, and C. Thorpe. Inactivation of general acyl-CoA dehydrogenase from pig kidney by a metabolite of hypoglycin A. J. Biol. Chem. 256: 9809-9812, 1981.
24. Williamson, J. R., and B. E. Corkey. Assays of intermediates of the citric acid cycle and related compounds by fluorometric enzyme methods. Methods Enzymol. 13: 434-512, 1967.
25. Williamson, J. R., M. H. Fukami, M. J. Peterson, S. G. Rostand, and R. Scholz. Effect of 4-pentenoic acid on coenzyme A metabolites in rat liver. Biochem. Biophys. Res. Commun. 36: 407-413, 1969.
26. Williamson, J. R., E. Walajtys-Rode, and K. E. Coll. Effects of branched chain α-ketoacids on the metabolism of isolated rat liver cells. J. Biol. Chem. 254: 11511-11520, 1979.
27. Wolff, J. A., J. E. Carroll, L. P. Thuy, C. Prodanos, R. Haas, and W. L. Nyhan. Carnitine reduces fasting ketogenesis in patients with disorders of propionate metabolism. Lancet 1: 289-291, 1986.